Vimarsana
Biggest News Aggregation in the World

Basaglar Kwikpen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Basaglar Kwikpen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Basaglar Kwikpen Today - Breaking & Trending Today

Eli Lilly to Withdraw Insulin Basaglar from Indian Market; Product No Longer Profitable, Say Experts - Vimarsana News

Eli Lilly to Withdraw Insulin Basaglar from Indian Market; Product No Longer Profitable, Say Experts

Published: September 14, 2023

American pharma major Eli Lilly has decided to withdraw insulin Glargine, sold under the brand name of Basaglar KwikPen, from the Indian market.

Source: news18.com
Related Topics:
United StatesEli LillyBasaglar KwikpenNational Pharmaceuticals Pricing AuthorityLilly IndiaMankind PharmaEris LifesciencesBringing Innovative MedsEli Lilly CompanyLi Lilly BangaloreLi Lilli IndiaEli Lilly And CompanyEli Lilly Share PriceInsulin InjectionInsulin ResistanceWhat Is Insulin
Navigating Medicare Insulin Coverage Still Requires Caution - Vimarsana News

Navigating Medicare Insulin Coverage Still Requires Caution

Published: January 18, 2023

Even with new federal caps on Medicare pay for insulin, people with diabetes need to choose insurance plans carefully to get the most help in managing drug costs, experts say.

Source: medscape.com
Related Topics:
United StatesNew YorkLantus SolostarAbigail ZugerDeidre WaxmanDavid LipschutzTresiba FlextouchStacieb DusetzinaNovolog FlexpenAlvaro BedoyaEli LillyClaire SachsKhrysta BaigLevemir FlextouchBasaglar KwikpenVanderbilt University Medical CenterMembers Of CongressKaiser Family FoundationCenters For MedicareNew York TimesHealth Insurance Assistance ProgramMedicaid ServicesInflation Reduction ActMedicare Partd Senior SavingsMedicare Partd Senior Savings Model